Cargando…

Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells

Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.

Detalles Bibliográficos
Autores principales: Xu, Lingling, Zhou, Chuan, Wang, Fan, Liu, Huiqin, Dong, Guangyuan, Zhang, Siyi, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248366/
https://www.ncbi.nlm.nih.gov/pubmed/35865561
http://dx.doi.org/10.1039/d2ra90065c
_version_ 1784739351960223744
author Xu, Lingling
Zhou, Chuan
Wang, Fan
Liu, Huiqin
Dong, Guangyuan
Zhang, Siyi
Liu, Tao
author_facet Xu, Lingling
Zhou, Chuan
Wang, Fan
Liu, Huiqin
Dong, Guangyuan
Zhang, Siyi
Liu, Tao
author_sort Xu, Lingling
collection PubMed
description Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.
format Online
Article
Text
id pubmed-9248366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-92483662022-07-20 Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells Xu, Lingling Zhou, Chuan Wang, Fan Liu, Huiqin Dong, Guangyuan Zhang, Siyi Liu, Tao RSC Adv Chemistry Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F. The Royal Society of Chemistry 2022-07-01 /pmc/articles/PMC9248366/ /pubmed/35865561 http://dx.doi.org/10.1039/d2ra90065c Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Xu, Lingling
Zhou, Chuan
Wang, Fan
Liu, Huiqin
Dong, Guangyuan
Zhang, Siyi
Liu, Tao
Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title_full Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title_fullStr Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title_full_unstemmed Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title_short Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
title_sort correction: functional drug carriers formed by rgd-modified β-cd-hpg for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248366/
https://www.ncbi.nlm.nih.gov/pubmed/35865561
http://dx.doi.org/10.1039/d2ra90065c
work_keys_str_mv AT xulingling correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT zhouchuan correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT wangfan correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT liuhuiqin correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT dongguangyuan correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT zhangsiyi correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells
AT liutao correctionfunctionaldrugcarriersformedbyrgdmodifiedbcdhpgforthedeliveryofdocetaxelfortargetedinhibitionofnasopharyngealcarcinomacells